Videos

Jubilant's John Teixeira

Jubilant's John Teixeira

Jubilant HollisterStier's lead for technical business liaison chats at Contract Pharma 2019.

By Contract Pharma Staff11.13.19
John Teixeira, lead, technical business liaison for Jubilant HollisterStier, talks about the company's specialized focus in sterile and niche pharmaceutical products.
Related Searches:
Suggested For You
CPhI Barcelona Event Info CPhI Barcelona Event Info
Aprecia Names Owen Murray as Its CEO Aprecia Names Owen Murray as Its CEO
Lonza Further Invests in Drug Product Manufacturing Capabilities Lonza Further Invests in Drug Product Manufacturing Capabilities
Strategies to Successfully Transfer & Scale Rx & OTC Drugs Strategies to Successfully Transfer & Scale Rx & OTC Drugs
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Asychem Partners with LaNova Medicines Asychem Partners with LaNova Medicines
Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
Symbiosis Completes Successful MHRA Audit Symbiosis Completes Successful MHRA Audit
Tower Cold Chain to Open New Global Headquarters in the UK Tower Cold Chain to Open New Global Headquarters in the UK
CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
Boyds Opens US Office in PA Boyds Opens US Office in PA
COVID Booster Vaccines: What’s Next for FDA COVID Booster Vaccines: What’s Next for FDA
Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer

Related Live From Shows

    Loading, Please Wait..